07-07-2022
News
Discover this Nature Communications paper describing how LentiFlash® RNA particles can be safely used to correct efficiently the Hutchinson-Gilford progeria syndrome mutation and improve skin pheno...
25-05-2022
Events
We are delighted to have met you at the ASGCT in Washington D.C, on May 16-19. The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting, celebrating its 25th year in 2022, is the...
27-04-2022
€15M, 3-year financing agreement with TECHLIFE CAPITAL and ELAIA PARTNERS
21-09-2021
We are pleased to announce that our team will be attending the 28th ESGCT Annual Meeting to be held virtually October 19-22, 2021
16-09-2021
Flash Therapeutics va doubler ses capacités de production de lots cliniques d’ici 2022 et amplifier la fabrication de lots à grande échelle à partir de 2023
Flash Therapeutics to double its clinical batch production capacity by 2022 and expand to large-scale batch manufacturing starting 2023
